These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 27092490)

  • 1. Molecular Mechanisms of the Anti-Obesity and Anti-Diabetic Properties of Flavonoids.
    Kawser Hossain M; Abdal Dayem A; Han J; Yin Y; Kim K; Kumar Saha S; Yang GM; Choi HY; Cho SG
    Int J Mol Sci; 2016 Apr; 17(4):569. PubMed ID: 27092490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review on Molecular Mechanism of Flavonoids as Antidiabetic Agents.
    Jasmin ; Jaitak V
    Mini Rev Med Chem; 2019; 19(9):762-786. PubMed ID: 30588881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-obesity and anti-diabetic effects of flavonoid derivative (Fla-CN) via microRNA in high fat diet induced obesity mice.
    Qin N; Chen Y; Jin MN; Zhang C; Qiao W; Yue XL; Duan HQ; Niu WY
    Eur J Pharm Sci; 2016 Jan; 82():52-63. PubMed ID: 26598088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flavonoids and Their Anti-Diabetic Effects: Cellular Mechanisms and Effects to Improve Blood Sugar Levels.
    Al-Ishaq RK; Abotaleb M; Kubatka P; Kajo K; Büsselberg D
    Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31480505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary Flavonoids and Insulin Signaling in Diabetes and Obesity.
    Martín MÁ; Ramos S
    Cells; 2021 Jun; 10(6):. PubMed ID: 34208379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor beta subtype selective agonist KB-141.
    Bryzgalova G; Effendic S; Khan A; Rehnmark S; Barbounis P; Boulet J; Dong G; Singh R; Shapses S; Malm J; Webb P; Baxter JD; Grover GJ
    J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):262-7. PubMed ID: 18621127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pomegranate as a Possible Treatment in Reducing Risk of Developing Wound Healing, Obesity, Neurodegenerative Disorders, and Diabetes Mellitus.
    AlMatar M; Islam MR; Albarri O; Var I; Koksal F
    Mini Rev Med Chem; 2018; 18(6):507-526. PubMed ID: 28425868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural flavonoids as potential herbal medication for the treatment of diabetes mellitus and its complications.
    Chen J; Mangelinckx S; Adams A; Wang ZT; Li WL; De Kimpe N
    Nat Prod Commun; 2015 Jan; 10(1):187-200. PubMed ID: 25920244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural compound renews hope for diabetes and obesity therapeutic target.
    Merk D; Schubert-Zsilavecz M
    Future Med Chem; 2015; 7(7):833-5. PubMed ID: 26061101
    [No Abstract]   [Full Text] [Related]  

  • 10. Dietary plant flavonoids in prevention of obesity and diabetes.
    Dinda B; Dinda M; Roy A; Dinda S
    Adv Protein Chem Struct Biol; 2020; 120():159-235. PubMed ID: 32085882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of antidiabetic effects of flavonoid rutin.
    Ghorbani A
    Biomed Pharmacother; 2017 Dec; 96():305-312. PubMed ID: 29017142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermogenesis and related metabolic targets in anti-diabetic therapy.
    Arch JR
    Handb Exp Pharmacol; 2011; (203):201-55. PubMed ID: 21484574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation effects of TZQ-F on adipocyte differentiation and insulin action.
    Nan Xia J; Qin Zhang D; Du J; Wen J
    J Ethnopharmacol; 2013 Nov; 150(2):692-9. PubMed ID: 24095827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes mellitus, inflammation, obesity: proposed treatment pathways for current and future therapies.
    Sonnett TE; Levien TL; Gates BJ; Robinson JD; Campbell RK
    Ann Pharmacother; 2010 Apr; 44(4):701-11. PubMed ID: 20233909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of beta 3-adrenoceptor agonists for the treatment of obesity and diabetes--an update.
    Weyer C; Gautier JF; Danforth E
    Diabetes Metab; 1999 Mar; 25(1):11-21. PubMed ID: 10335419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genistein: a promising therapeutic agent for obesity and diabetes treatment.
    Behloul N; Wu G
    Eur J Pharmacol; 2013 Jan; 698(1-3):31-8. PubMed ID: 23178528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer.
    Polvani S; Tarocchi M; Tempesti S; Bencini L; Galli A
    World J Gastroenterol; 2016 Feb; 22(8):2441-59. PubMed ID: 26937133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flavonoids in the Treatment of Diabetes: Clinical Outcomes and Mechanism to Ameliorate Blood Glucose Levels.
    Al Duhaidahawi D; Hasan SA; Al Zubaidy HFS
    Curr Diabetes Rev; 2021; 17(6):e120720188794. PubMed ID: 33290200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive effect of Kaempferia parviflora ethyl acetate extract and its major components polymethoxyflavonoid on metabolic diseases.
    Shimada T; Horikawa T; Ikeya Y; Matsuo H; Kinoshita K; Taguchi T; Ichinose K; Takahashi K; Aburada M
    Fitoterapia; 2011 Dec; 82(8):1272-8. PubMed ID: 21907268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.